- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02778230
Efficacy of Pea Hull Fibre Supplementation
April 3, 2019 updated by: University of Florida
Efficacy of Pea Hull Fibre Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Older Adults.
The purpose of this randomized, cross-over study is to explore the effects of pea hull fiber on bowel movement frequency, transit time, appetite, gastrointestinal symptoms, microbiota composition and activity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A 10-week randomized, cross-over study will be carried out to assess the efficacy of pea hull fiber.
Participants will complete a 2-week baseline period during which appetite, gastrointestinal symptoms, stool frequency, and stool consistency (transit time) will be collected by paper questionnaire, and participants will collect a single stool.
Dietary data (24-hour dietary recalls) will be obtained via phone interviews 3 times during the baseline period.
On or about day 15, participants will attend a study visit and complete the Simplified Nutritional Appetite Questionnaire (SNAQ) and Gastrointestinal Symptom Response Scale (GSRS).
Participants will be randomized on or about day 15 and consume snacks without pea hull fiber for a 2-week control period, and snacks with added pea hull fiber for a 2-week treatment period separated by a 2-week washout period.
In both intervention periods, participants will complete daily questionnaires to assess appetite, gastrointestinal symptoms, and stool frequency and consistency (transit time).
Furthermore, they will complete SNAQ and GSRS after the end of each intervention period.
The 24-hour dietary recalls will also be collected 3 times during each of the intervention periods.
Participants will undergo an additional 2-week washout period after the second intervention period.
During washout periods, the same data will be collected as was done during the baseline and intervention periods.Participants will be asked to collect one stool during pre-baseline and weeks 4, 6, 8 and 10 for a total of 5 stools.
Stool samples will be analyzed for changes in the microbiota.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- Food Science and Human Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willing to have height and weight measured and provide demographic information (e.g. age, race, sex).
- Willing to consume pea hull fiber and control snacks daily each for a 2-week period
- Willing to complete a daily questionnaire regarding general and gastrointestinal wellness throughout the entire 10-weeks study.
- Willing to complete the GSRS (Gastrointestinal Symptom Rating Scale) and SNAQ questionnaires bi-weekly at study appointments.
- Willing to be interviewed for a 24-hr food recall, 3 times per 2-weeks period throughout the study.
- Willing to provide 5 stool samples, one in each 2-weeks period throughout the study.
- Willing and be able to provide a valid social security for study payment purposes.
Exclusion Criteria:
- Have any known food allergies.
- Are currently taking medications for diarrhea.
- Have taken antibiotics within the past four weeks prior to randomization.
- Are currently taking probiotics supplements and do not want to discontinue a minimum of two weeks prior to the study.
- Have previously or are currently being treated for any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's, Celiac, ulcerative colitis, etc.).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pea Fiber
Two fiber snacks fortified with 5 g/each of pea fiber (Best Pea Fiber 200) will be consumed each day for a period of two weeks.
|
Snacks (2 baked goods) fortified with 5 g pea hull fiber
|
Other: Control
Two control snacks will be consumed each day for a period of two weeks.
|
Snacks (2 baked goods) without fiber fortification.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stool consistency rating by Bristol Stool Form Scale
Time Frame: Changes from baseline to week 4, 6, 8 and 10.
|
Assesses estimated transit time.
|
Changes from baseline to week 4, 6, 8 and 10.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of bowel movements per day averaged by week
Time Frame: Changes from baseline to week 4, 6, 8, and 10
|
stool frequency
|
Changes from baseline to week 4, 6, 8, and 10
|
Microbiota profile changes: percent change at phylum and genus levels; changes in OTUs
Time Frame: Changes from baseline to week 4, 6, 8, and 10
|
Changes from baseline to week 4, 6, 8, and 10
|
|
GSRS (Gastrointestinal Symptom Response Scale) score.
Time Frame: Changes from baseline to week 4, 6, 8, and 10
|
Changes from baseline to week 4, 6, 8, and 10
|
|
SNAQ (Simplified Nutritional Appetite Questionnaire) score.
Time Frame: Changes from baseline to week 4, 6, 8, and 10
|
Changes from baseline to week 4, 6, 8, and 10
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
December 27, 2018
Study Registration Dates
First Submitted
May 12, 2016
First Submitted That Met QC Criteria
May 17, 2016
First Posted (Estimate)
May 19, 2016
Study Record Updates
Last Update Posted (Actual)
April 5, 2019
Last Update Submitted That Met QC Criteria
April 3, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB201600646
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
No current plan.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Pea Fiber
-
Washington University School of MedicineCompletedMicrobial ColonizationUnited States
-
University of FloridaSaskatchewan Pulse GrowersCompleted
-
University of FloridaSaskatchewan Pulse GrowersCompleted
-
University of TorontoAgriculture and Agri-Food Canada; Pulse CanadaCompletedObesity | Metabolic Syndrome | Type II Diabetes MellitusCanada
-
University of TorontoAgriculture and Agri-Food CanadaCompletedObesity | Metabolic Syndrome | Type II Diabetes MellitusCanada
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompleted
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompletedDiabetes Prevention | Obesity Prevention
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompleted
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompleted
-
University of BonnGerman Federal Ministry of Education and Research; University of Bonn, Department...Active, not recruitingPlasma Amino Acid Appearance and Disappearance | Postprandial Metabolic EventsGermany